This three-day course will provide the attendee with a multidisciplinary review of standard of care management practices and state-of-the-art advances in care of the patient with cutaneous melanoma. The first day will focus on epidemiology, prevention, pathology, surgical treatment and advances in genomics and systemic therapy for patients with melanoma.
The last two days are an in-depth immersion into dermoscopy for imaging of melanocytic and nonmelanocytic skin lesions, including three breakout sessions. Participants will develop practical skills that will enable them to be more comfortable approaching patients with atypical skin lesions. This dermoscopy section is primarily targeted to clinicians, but NPs/PAs and residents with a focus on this field will find it valuable as well. The intended audience is dermatologists, surgeons, oncologists, physicians in internal medicine, family practice, and general practice.
Apply pattern analysis and simple algorithms for the identification of skin neoplasms.
Differentiate melanocytic from non-melanocytic lesions.
Identify non-melanocytic lesions using dermoscopy.
Assess the need to biopsy based on dermoscopic findings.
Describe the specific regional variations for melanocytic morphologies
Identify situations where dermoscopy is not useful.
Differentiate other uses for dermoscopy than the analysis of neoplasms.
Define the epidemiology, incidence, and risk factors of cutaneous melanoma.
Evaluate the important aspects of pathology reports for melanoma and identify the relevant prognostic information.
Review the standard surgical techniques for biopsy and excision of primary melanoma.
Summarize the 2 step dermoscopic algorithm and approach for cutaneous lesions.
Review the recent clinical technology for monitoring high risk patients and diagnosing melanoma.
Apply recent data regarding excision and sentinel lymph node dissections.
Review treatment of lentigo maligna and desmoplastic melanoma.
Review emerging experimental approaches to adjuvant treatment.
Examine the use of topical therapy for the treatment of in transit or locally recurrent melanoma.
Apply novel immunotherapy and targeted therapy to multidisciplinary approach of the patient with metastatic melanoma.
Assess prognosis and treatment of merkel cell carcinoma.
Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.